导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 8.51% | 318/1050 |
| 近一周 | -0.57% | 73/1104 |
| 近一月 | -3.43% | 409/1102 |
| 近一季 | -2.03% | 327/1092 |
| 近半年 | 8.36% | 266/1070 |
| 近一年 | 13.73% | 312/1018 |
| 近两年 | 60.11% | 429/926 |
| 近三年 | 45.45% | 286/834 |
| 成立以来 | 12.93% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.66% 792/1070 |
32.18% 304/1101 |
- - |
- - |
| 2025 | 27.24% 527/1065 |
2.71% 580/1014 |
-1.32% 801/1038 |
27.32% 406/1050 |
-1.40% 523/1065 |
| 2024 | 13.83% 201/1011 |
5.72% 94/960 |
1.81% 204/983 |
9.76% 635/991 |
-3.64% 583/1011 |
| 2023 | -18.66% 641/952 |
-1.39% 682/880 |
-7.30% 654/895 |
-4.59% 275/915 |
-6.73% 652/952 |
| 2022 | -25.14% 499/867 |
-17.75% 412/773 |
8.82% 309/806 |
-10.91% 298/845 |
-6.11% 674/867 |
| 2021 | -11.66% 497/740 |
-2.87% 259/580 |
5.87% 450/659 |
-12.33% 567/704 |
-2.02% 512/740 |
| 2020 | - - |
- - |
22.37% 244/466 |
7.61% 310/517 |
14.27% 220/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 南方内需增长两年股票C VS. 东吴新产业精选股票A(580008) |